
    
      Subjects will first be dispensed preservative-free 0.9% saline eye drops (saline eye drops)
      to be used during the Run-in phase between Screening Visit and Day 0 (Visit 1). Subjects who
      qualify will be randomized in a 1:1 manner to receive either treatment with SYSTANEÂ®
      HYDRATION Lubricant Eye Drops or Hyabak 0.15% Eye Drops.
    
  